Mirae Asset Global ETFs Holdings’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$161K Sell
4,694
-521
-10% -$15.3K ﹤0.01% 2592
2026
Q1
$161K Buy
5,215
+136
+3% +$3.35K ﹤0.01% 2459
2025
Q4
$106K Sell
5,079
-55
-1% -$1.02K ﹤0.01% 2650
2025
Q3
$80.6K Sell
5,134
-878
-15% -$18.1K ﹤0.01% 2763
2025
Q2
$119K Buy
+6,012
New +$122K ﹤0.01% 2516

Other funds holding TECX

Mirae Asset Global ETFs Holdings's TECX Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings reduced its Tectonic Therapeutic (TECX) stake by 10% in Q2 2026, selling an estimated $15.3K and leaving 4,694 shares worth $161K. The position accounts for ﹤0.01% of the portfolio, ranked #2592.

Mirae Asset Global ETFs Holdings first reported a position in TECX in Q2 2025 and has held it in 5 quarters since. 122 funds tracked by Wall St. Rank hold TECX as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 4,694 shares of Tectonic Therapeutic worth $161K as of Q2 2026.
  • Mirae Asset Global ETFs Holdings sold 521 Tectonic Therapeutic shares in Q2 2026, an estimated $15.3K.
  • Tectonic Therapeutic made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #2592 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Tectonic Therapeutic in Q2 2025 and has held it in 5 quarters since.
  • 122 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.